Cargando…
In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity
Rabies causes more than 60,000 human deaths annually in areas where the virus is endemic. Importantly, rabies is one of the few pathogens for which there is no treatment following the onset of clinical disease with the outcome of infection being death in almost 100% of cases. Whilst vaccination, and...
Autores principales: | Phoolcharoen, Waranyoo, Banyard, Ashley C., Prehaud, Christophe, Selden, David, Wu, Guanghui, Birch, Colin P.D., Szeto, Tim H., Lafon, Monique, Fooks, Anthony R., Ma, Julian K.-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677913/ https://www.ncbi.nlm.nih.gov/pubmed/29523449 http://dx.doi.org/10.1016/j.vaccine.2018.02.057 |
Ejemplares similares
-
Enhanced transport of plant‐produced rabies single‐chain antibody‐RVG peptide fusion protein across an in cellulo blood–brain barrier device
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2017) -
Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2022) -
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014) -
New human rabies vaccines in the pipeline
por: Fooks, Anthony R., et al.
Publicado: (2019) -
Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2021)